Why We Invest in Biopolymers

Derived from renewable feedstocks, biopolymers offer a credible alternative to fossil-fuel based materials and align with demand for eco-friendly materials and corporate commitments to carbon neutrality and circular economy models. This makes biopolymers a solution to waste and a reputational asset for investors seeking to demonstrate environmental responsibility.

Future Proof Investments

Measures such as the European Union’s Single-Use Plastics Directive and national carbon-neutral pledges (such as Austria’s commitment to carbon neutrality by 2040) are reshaping the plastics industry, generating demand for bioplastics like Polylactic Acid (PLA) and Polyhydroxyalkanoates (PHA). With a phasing out of fossil fuels and fossil fuel-based products, investors in traditional plastics could end up with stranded assets. On the other hand, biopolymers are future-proof investments. Combined with regulatory frameworks, investing in biopolymers has less risk than investing in fossil fuel-based materials.

Technology

Technological advances further enhance the appeal. Early biopolymers relied on food-based feedstocks such as corn and sugarcane, raising concerns about competition with food systems. Today, innovation is shifting towards other sources such as agricultural waste and algae that improve scalability and sustainability. Thanks to these breakthroughs, biopolymers such as PHAs can be used in packaging, medical devices and textiles. This expands their commercial viability and diversifies revenue streams. Companies such as CO2BioClean use patented technology to tap into new source materials for biopolymers. For CO2BioClean, the answer is converting industrial carbon emissions into sustainable materials.

The Power of Collaboration

Investing in biopolymers also opens the door for collaboration for growth. Strategic partnerships with other biopolymer manufacturers, chemical companies and consumer goods manufacturers provide off-take agreements, ensuring stable demand and economies of scale. These collaborations reduce uncertainty and accelerate the path to profitability. Plastrans Technologies has harnessed the power of partnership to expand its offerings. The latest result of this approach is the Bio Net project, which won 3rd prize at the 2026 Biopolymer Innovation Award.

Investing in biopolymers positions Ghazan Global at the intersection of sustainability, consumer preferences, and regulatory compliance, while tapping into a sector projected for sustained growth. With investments in three manufacturers, biopolymers are a crucial part of our future-oriented investment portfolio.